TLR4 has been shown to be extensively involved in stroke, myocardial infarction and inflammation, where its binding to the bridging molecules MyD88 or MAPK activates NF-κB and triggers the up-regulation of IL-1β, IL-18 and TNF-α expression (132–134). Here, NFKB1 is linked to stroke disorder.